Logo of jbacterPermissionsJournals.ASM.orgJournalJB ArticleJournal InfoAuthorsReviewers
J Bacteriol. 2006 Jan; 188(1): 132–140.
PMCID: PMC1317580

The Pseudomonas aeruginosa Ribbon-Helix-Helix DNA-Binding Protein AlgZ (AmrZ) Controls Twitching Motility and Biogenesis of Type IV Pili


Pseudomonas aeruginosa is an opportunistic pathogen that is commonly found in water and soil. In order to colonize surfaces with low water content, P. aeruginosa utilizes a flagellum-independent form of locomotion called twitching motility, which is dependent upon the extension and retraction of type IV pili. This study demonstrates that AlgZ, previously identified as a DNA-binding protein absolutely required for transcription of the alginate biosynthetic operon, is required for twitching motility. AlgZ may be required for the biogenesis or function of type IV pili in twitching motility. Transmission electron microscopy analysis of an algZ deletion in nonmucoid PAO1 failed to detect surface pili. To examine expression and localization of PilA (the major pilin subunit), whole-cell extracts and cell surface pilin preparations were analyzed by Western blotting. While the PilA levels present in whole-cell extracts were similar for wild-type P. aeruginosa and P. aeruginosa with the algZ deletion, the amount of PilA on the surface of the cells was drastically reduced in the algZ mutant. Analysis of algZ and algD mutants indicates that the DNA-binding activity of AlgZ is essential for the regulation of twitching motility and that this is independent of the role of AlgZ in alginate expression. These data show that AlgZ DNA-binding activity is required for twitching motility independently of its role in alginate production and that this involves the surface localization of type IV pili. Given this new role in twitching motility, we propose that algZ (PA3385) be designated amrZ (alginate and motility regulator Z).

Pseudomonas aeruginosa is a formidable opportunistic pathogen causing deadly infections in individuals who are burn patients, undergoing cancer chemotherapy, or have the genetic disease cystic fibrosis (CF) (27). Initial colonizing strains in the CF lung have a nonmucoid phenotype, but gradually mucoid strains emerge (16). This mucoid phenotype is due to the overproduction of the exopolysaccharide alginate (14). This trait provides adherence properties and protects bacteria from the immune system, allowing P. aeruginosa to chronically infect the lung. For CF patients, chronic lung colonization by mucoid strains of P. aeruginosa leads to a potent inflammatory response and tissue destruction, with the eventual result in the vast majority of patients being respiratory failure and death (17).

Most of the biosynthetic genes required for alginate production are located in a large operon. Activation of algD, the first gene in this operon, is absolutely required for alginate production, and its expression is tightly controlled (10, 49). A number of genes have been shown to mediate control of algD transcription, including the alternative sigma factor AlgT (AlgU, σE) that is part of a family of sigma factors that regulate extracytoplasmic functions (13, 28). The mucABCD genes adjacent to algT negatively regulate the activity of AlgT. Mutations in these genes result in an active AlgT and subsequent transcription of genes, resulting in mucoidy (3, 15, 29). Regulators of algD that have been shown to be under AlgT control include the response regulator proteins AlgB and AlgR and the ribbon-helix-helix (RHH) DNA-binding protein AlgZ (GenBank accession number AF139988 and Pseudomonas aeruginosa Genome Database [http://www.pseudomonas.com/current_annotation.asp] designation PA3385) (2, 49, 50). AlgR and AlgZ regulate algD by directly binding to sequences far upstream of the promoter. Each of these regulatory genes is required, but none appear to be sufficient for expression of the mucoid phenotype (1, 49).

In addition to alginate production, another important P. aeruginosa virulence factor is type IV pili (TFP). These polar appendages are responsible for attachment to epithelia, biofilm development (likely including DNA binding), and twitching motility (TM) (30, 38). TM allows P. aeruginosa to travel across solid surfaces via the extension and retraction of TFP (4). More than 40 genes have been identified as involved in TFP function or the regulation of TM. A loss of the TFP complex or the ability to extend and retract TFP results in cells that are avirulent in cytotoxicity with murine models of infection (9, 30).

Our laboratories have focused on the study of the proposed RHH DNA-binding protein AlgZ (1). Other members of this family, such as Mnt and Arc of Salmonella enterica serovar Typhimurium phage P22 (8, 39, 40) and NikR (8) of Escherichia coli, are repressors, while AlgZ was identified as a transcriptional activator (2). Recently, it has been found that AlgZ binds its own promoter and also represses transcription (31). Our search of the literature has not identified any other RHH protein that has been identified as both an activator and a repressor in vivo. All previous studies of AlgZ have been undertaken with mucoid P. aeruginosa strains. In the present work, we examined the potential role of AlgZ in the control of genes in the nonmucoid strain PAO1. We discovered that PAO1-dervied algZ mutants were deficient in TM. The role of algZ in TM was shown to require its DNA-binding activity but was independent of its role in algD activation. Transmission electron microscopy and antipilin Western blot analysis of surface and whole-cell preparations suggest that algZ is required for proper assembly of surface-exposed TFP but not for expression of the major subunit pilA. Because of its dual role in controlling both alginate production and TFP-mediated TM, we propose that algZ (GenBank accession numbers AF139988 and PA3385) be renamed amrZ (alginate and motility regulator Z).


Bacterial strains, plasmids, and oligonucleotides.

All P. aeruginosa strains used in this study originated from PAO1 and are listed in Table Table1.1. WFPA203 was constructed by inserting an arabinose-inducible amrZ at the neutral attB site with pJF2, a mini-CTX-based plasmid (19), whose construction is described below. Subsequently, pAB3 was used to replace the wild-type amrZ with an omega tetracycline cassette as described previously (31). Plasmid pJF2 was constructed by cloning the product of a PCR amplification with template pPJ145, which was previously described (50), and primers pET1 and pET2 into the EcoRI-SmaI site of pSW196. This plasmid was then mobilized into PAO1 via E. coli strain SM10. The plasmid was integrated at the chromosomal attB site via the plasmid-encoded site-specific integrase (19). The cloning site in this vector is flanked by Saccharomyces cerevisiae Flp recombinase target sites. These sites facilitated in vivo excision of the plasmid, including the antibiotic resistance marker, via the Flp recombinase that was supplied on a different plasmid (pFLP2) via conjugation. This plasmid was cured via the plasmid-encoded sacB counterselectable marker (19). The pPJ145 template used contains the wild-type amrZ and has been previously described (50). pSW196 contains the promoter from pBAD30 (18) and a small multiple cloning site (EcoRI, PstI, SmaI, NotI, and SacI) cloned into mini-CTX (19). Briefly, pSW161, which has been previously described (46), was cut with EcoRI and HindIII, and a corresponding fragment containing algT was inserted (pSW186); this was then cleaved with EcoRI to remove the small polylinker with a KpnI site (pSW192). The KpnI-HindIII fragment containing algT with the polylinker and pBAD sequences was then cloned into the corresponding sites of mini-CTX (19) (pSW195), and the algT sequences were removed by cleavage with EcoRI and re-ligation (pSW196).

Strains, plasmids, and primers used in this study

The PAO1 strains with mutations in the putative amrZ DNA-binding domain were constructed starting with a PAO1 ΔamrZ::tet strain (WFPA205). WFPA205 was constructed using pAB3 to replace the wild-type amrZ with an omega tetracycline cassette as described previously (31). Isogenic strains with the indicated mutations were constructed by allelic exchange of the omega tetracycline cassette with the designated amrZ allele. The alleles were constructed using site-directed mutagenesis (Promega Altered Sites) with the indicated oligonucleotides. Each mutant oligonucleotide was used with the plasmid pPJ136 (the 1.8-kb BamHI-HindIII fragment from pDJW585 containing amrZ in pAlter). A chromosomal R22A mutation was introduced as described previously (31). Briefly, pPJ136 and mutagenic oligonucleotide amrZ19 resulted in pPJ150 (amrZ R22A). The BamHI-HindIII fragment of this plasmid was cloned into pEX18Ap, resulting in pPJ157 (31). With the mutagenic oligonucleotide amrZ18, pPJ149 (amrZ V20A) was constructed and the BamHI-HindIII fragment was subcloned into pEX18Ap, resulting in pPJ156. With mutagenic oligonucleotide amrZ17, pPJ148 (amrZ K18A) was constructed and the BamHI-HindIII fragment was then cloned into pEX18Ap to produce pPJ155. The wild-type allele (pDJW585) and each construct (pPJ155, pPJ156, and pPJ157) were substituted for the ΔamrZ::Ωtet allele of WFPA205. This resulted in strains WFPA510 (complemented strain, amrZΔ amrZ+), WFPA511 (amrZ K18A), WFPA512 (amrZ V20A), and WFPA513 (amrZ R22A), respectively.

Site-directed mutagenesis of pPJ136 was used with mutant oligonucleotide amrZ17 to generate the amrZ17 allele (K18A, pPJ148). In the same manner, mutant oligonucleotide amrZ18 was used to generate the amrZ18 allele (V20A, pPJ149). The amrZ19 allele (R22A, pPJ150) was constructed as previously described (31). To generate six-His-tagged alanine mutants of AmrZ, the mutant alleles were cloned into the BamHI-EcoRI sites of pTrcHisA (Invitrogen) by using primers amrZ26 and amrZ27 and template pPJ148, pPJ149, or pPJ150, resulting in pHL20 (AmrZ K18A), pHL21 (AmrZ V20A), and pHL22 (AmrZ R22A), respectively. Wild-type six-His-tagged AmrZ was constructed as previously described (31).

Cleared extracts derived from E. coli JM109/pDR2 and alanine substitution mutants were prepared as previously described (31). In brief, the cleared extract was added to a slurry containing Ni-nitrilotriacetic acid magnetic agarose beads (QIAGEN) and binding buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0), and the sample was allowed to mix at 4°C for 1 hour. Residual proteins were removed with two wash steps, and the pure protein was eluted from the beads by the addition of binding buffer containing 1 M imidazole and 0.005% Tween. Protein expression and purification steps were monitored by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and staining with Coomassie brilliant blue (Fisher).

DNA-binding assays and conditions are similar to those previously reported (2, 31). In brief, increasing amounts of purified wild-type N-terminal six-His AmrZ or alanine substitution mutants (AmrZ K18A, AmrZ V20A, and AmrZ R22A) were incubated in a DNA-binding assay with an end-labeled algD fragment amplified from template pDJW221 by using primers algD5 and algD7 (1, 48). All DNA-binding assays were performed at 25°C for 10 min in a reaction volume of 10 μl and processed as previously described (2). Gels were dried at 80°C for 20 min and exposed to a phosphorimaging screen for variable amounts of time.

Media and chemicals.

All P. aeruginosa strains were cultured in LBNS (10 g liter−1 tryptone and 5 g liter−1 yeast extract) or on LANS (LBNS with 15 g liter−1 agar). E. coli strains were grown in LB (10 g liter−1 tryptone, 5 g liter−1 yeast extract, 5g liter−1 sodium chloride) or on LA (LB with 15 g liter−1 agar). Incubations were carried out at 37°C. Antibiotic concentrations (when necessary) for culture of E. coli were as follows: for tetracycline, 15 μg/ml; for ampicillin, 100 μg/ml; and for gentamicin, 15 μg/ml. For P. aeruginosa, antibiotics were used at the following concentrations: tetracycline, 100 μg/ml; carbenicillin, 300 μg/ml; and gentamicin, 100 μg/ml. The medium for culturing of P. aeruginosa strains after mating was LANS supplemented with Irgasan (25 μg/ml). Sucrose counterselection via sacB was performed at 30°C with 5% sucrose in LANS. All chemicals were obtained from Sigma unless otherwise stated.

Twitching motility assays.

Twitching motility was assayed by stab inoculating strains through a thin 1% LANS plate containing 0.1% tetrazolium red (with 2% arabinose supplementation where indicated) with 24 to 48 h of incubation at 37°C under humidified conditions. Twitching motility zones were visualized at the agar plate interface (43).

Transmission electron microscopy (TEM).

Bacterial strains were inoculated onto LANS plates and placed at 37°C overnight. After 12 h, the plates were flooded with 3 ml of LBNS and the colonies were gently suspended. From each plate, 1.0 ml was collected and placed into microfuge tubes. Copper grids were treated with 100% ethyl alcohol for 1 minute. A fresh suspension of each strain was placed on the corresponding grid, barely covering the darker side of the grid. After 1 minute, the edge of the grid was wicked with filter paper. The treated surface of the grid was washed with cold double-distilled water three times. Upon washing, the excess of moisture was wicked from the grid. A drop of 2% uracyl acetate was placed on the grid for 1 minute to negatively stain the sample. The grid was dried with filter paper from the edge. Visualization up to ×25,000 was made via a Philips TEM 400 (Micromed, Wake Forest University School of Medicine). The images are of a representative bacterium that corresponded to 90 to 95% of those observed for each strain analyzed.

Western blot assays.

Whole-cell PilA preparations for Western blotting were prepared by resuspending bacterial cultures from plates in LBNS to an optical density of 1.0 at 600 nm. Samples (1 ml) were centrifuged, and the pellets were resuspended in 50 μl of 1× loading buffer (0.25 M Tris-HCl, pH 6.8, 10% glycerol, 2% sodium dodecyl sulfate, 0.0125% bromophenol blue, 5% 2-mercaptoethanol). Chromosomal DNA was sheared by drawing samples through a 27.5-G needle approximately 10 to 20 times or until the solution was no longer viscous. The samples were boiled for 4 min, resolved in a 4 to 20% precast gel (Bio-Rad Laboratories) via sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and transferred electrophoretically using a semidry transfer apparatus (Bio-Rad) to Immobilon-P polyvinylidene difluoride membranes (Millipore). PilA was detected with anti-PilA antibody (a gift of Randall Irving) used at a concentration of 1:5,000 in Tris-buffered saline (20 mM Tris base, 137 mM NaCl, pH 7.6) with 0.1% Tween 20, followed by donkey anti-rabbit immunoglobulin G, horseradish peroxidase-linked antibody (Amersham Biosciences). Chemiluminescent detection reagents (Amersham Biosciences) were used according to the manufacturer's procedure, and CL-XPosure Clear-Blue X-ray film (Pierce Biotechnology) was exposed to the blots and developed. Fimbrial-surface preparations for Western blotting were prepared as done previously (45) by scraping whole plates of bacteria into 1.5 ml phosphate-buffered saline (8 g liter−1 NaCl, 1.16 g liter−1 Na2HPO4, 0.2 g liter−1 KH2PO4, 0.2 g liter−1 KCl, pH 7.0). Samples were vortexed to resuspend bacteria and to shear the fimbriae from the cell surface. The cells were centrifuged twice, and the supernatants were transferred to fresh 1.5-ml microfuge tubes. MgCl2 (1 M, 150 μl) was added to precipitate the fimbriae, and the tubes were vortexed briefly and placed at 4°C overnight. The TFP were pelleted by centrifugation and resuspended in 100 μl of 1× loading buffer. Samples were resolved and detected as described above. When included, flagellin-specific antibody was provided at a 1:20,000 dilution. Loading control gels were stained with Gelcode Blue (Pierce) as instructed by the manufacturer.


AmrZ (AlgZ) is required for twitching motility, and this role does not involve alginate production.

While AmrZ (previously referred to as AlgZ, encoded by algZ [PA3385]) was identified as a DNA-binding protein required for the production of alginate in mucoid P. aeruginosa isolates (2), it was unclear what role this protein may play in nonmucoid strains, which are the predominant phenotype found in the environment and in acute-infection isolates. An amrZ deletion was constructed in the nonmucoid strain PAO1, and this resulted in a domed-colony morphology lacking a rough “ground glass” edge. This phenotype was suggestive of a defect in TM (35). Complementation was accomplished by placing an arabinose-inducible amrZ at the neutral attB site. This resulted in the wild-type spreading, rough-edged colony type of the parental PAO1 strain upon arabinose induction (data not shown).

TM assays were performed in order to more precisely analyze the TM phenotype of these strains (Fig. (Fig.1A).1A). This involved stab inoculation of a 1% agar plate and visualization of TFP-mediated growth at the agar plate interface by utilizing tetrazolium red. In the absence of arabinose, only PAO1 (Fig. (Fig.1A)1A) demonstrates a halo of bacterial motility at the agar plate interface. Both the amrZ deletion strain (WFPA205) and the deletion strain containing an inducible amrZ (WFPA203) are TM deficient. However, in the presence of arabinose, both PAO1 and WFPA203 demonstrate a TM+ phenotype (Fig. (Fig.1B),1B), as WFPA203 is complemented by the arabinose-inducible amrZ. These data indicate a previously unrecognized role for amrZ in the control of TM. This was not due to a growth defect, since the amrZ deletion and parental PAO1 strain have similar growth curves under rich-medium growth conditions (data not shown). Due to its function as a regulator of at least two distinct surface components in P. aeruginosa, the algZ gene is now given the designation amrZ (alginate and motility regulator Z).

FIG. 1.
TM analysis of amrZ and algD strains. A thin 1% agar plate containing LA with no sodium chloride and tetrazolium red without (A) or with (B) 2% arabinose supplementation was stab inoculated to the bottom of the plate and incubated for 24 to 48 h at 37°C. ...

Since amrZ is required both for the production of alginate and for TM, the simplest explanation would be that alginate may be required for TM. Perhaps this exopolysaccharide aids in TM by decreasing friction and allowing the bacteria to move more easily. In order to address this possibility, an isogenic strain (WFPA1) in which algD was deleted was constructed and the TM phenotypes of the amrZ and algD deletion strains were examined (Fig. (Fig.1C).1C). WFPA1 displays a TM+ phenotype, compared with WFPA205 (amrZ deletion) (Fig. (Fig.1C),1C), which is TM. This indicates that alginate is not required for TM and that the role AmrZ plays in TM is independent of algD activation.

TEM reveals that the amrZ deletion strain produces no detectable surface pili.

Previously, Bradley found that many TM mutants lacked functional TFP and were either apiliate or hyperpiliated (4). In order to determine the phenotype of the amrZ deletion strain with regard to production of pili, the surfaces of the various bacterial strains were analyzed via TEM. Upon examination of numerous negatively stained cells, no TFP were visualized on the surface of bacteria harboring a deletion in pilA or amrZ, while the wild-type PAO1 strain clearly possessed these appendages (Fig. (Fig.2).2). These data suggest that amrZ is required for pilA expression, TFP assembly, or TFP export.

FIG. 2.
TEM analysis of P. aeruginosa strains. Bacteria were harvested from plates cultured overnight, negatively stained using 2% uracyl acetate, and visualized using a Philips TEM 400. Strains analyzed were (A) PAO1 (wild type), (B) AWO (pilA deletion), and ...

AmrZ is required for proper surface localization of TFP but not for pilA expression.

In order to determine whether amrZ plays a role in pilA expression, we prepared whole-cell extracts of PAO1, AWO (pilA deletion), WFPA205 (amrZ deletion), and WFPA203 (amrZ deletion with an arabinose-inducible amrZ at attB) both with and without arabinose supplementation and analyzed these via Western blotting using antipilin antibodies (Fig. (Fig.3A).3A). Bacteria were harvested from plates, and the numbers of cells used were normalized by dilution of the samples to the same optical density at 600 nm. A stained gel of the samples indicates that similar amounts of total protein were in each lane (Fig. (Fig.3C).3C). The amounts and masses of PilA present in the wild-type PAO1 strain and the amrZ deletion strains are similar, while PilA is not detectable in the pilA deletion strain AWO (Fig. (Fig.3A,3A, compare lanes 1, 3, and 4 to lane 2). This indicates that amrZ is not required for pilA expression or PilA maturation. Since the amount of PilA in the amrZ deletions was similar to that of the wild type, we wanted to determine if the TM defect was due to PilA export or TFP assembly. To address this, we made fimbrial-surface preparations of the above strains and subjected these to Western blot analysis (Fig. (Fig.3B).3B). In order to confirm that similar amounts of the preparations were loaded into each lane, antiflagellin antibody was used in addition to anti-PilA antibody in probing the blots of the surface samples. The amount of flagellin detected in each lane is similar, indicating that comparable numbers of cells were analyzed (Fig. (Fig.3D).3D). Compared to the wild-type strain, which possesses copious amounts of surface PilA, the amrZ deletions show extremely low levels (Fig. (Fig.3B,3B, compare lane 1 with lanes 3 and 4). When arabinose is supplied in order to induce amrZ in the WFPA203 strain (amrZ deletion with an arabinose-inducible amrZ at attB), the result is wild-type amounts of surface PilA (Fig. (Fig.3B,3B, lane 5). This confirms the TEM data and demonstrates that amrZ is required for proper localization of wild-type amounts of TFP.

FIG. 3.
Analysis of PilA production and localization via Western blotting. Whole-cell extracts (A) with identical samples in a stained-gel control (C) and sheared-surface TFP (B) were visualized via Western blotting with enhanced chemiluminescence (ECL) detection. ...

AmrZ DNA binding is required for TM.

Since AmrZ-mediated autoregulation and algD expression require the DNA-binding activity of AmrZ (2, 31), we examined if this is the case with TM. The amino termini of the RHH DNA-binding proteins Arc and Mnt are responsible for operator recognition and binding, forming a unique DNA-binding domain (22). The DNA-binding domains of the dimeric protein Arc (53 residues, monomer) and the tetrameric protein Mnt (82 residues, monomer) are similar in structure and assume the shape of an orthogonal bundle (37). The orthogonal bundle is comprised of a beta-strand, which contacts DNA, followed by two alpha helices that form a coiled coil and comprise a dimerization domain (6). Previous studies have shown that residues Arg2, His6, Asp8, and Arg10 of Mnt are responsible for operator recognition and binding (21). Of the first 26 residues of the N terminus of AmrZ, residues 13 to 26 share amino acid identity with the beta strands of Arc and Mnt (Fig. (Fig.4A)4A) (1).

FIG. 4.
Amino acid residues K18 and R22 are absolutely required for binding of AmrZ to the algD promoter. (A) Amino acid alignment between Arc (residues 1 to 53) and AmrZ (residues 10 to 62). Amino acid residues that correspond to the beta-strand (Arc residues ...

We first addressed whether these residues would be required for DNA-binding activity to a published AmrZ-binding target. To test this, we engineered amino acid substitutions in place of AmrZ residues K18, V20, and R22 by using site-directed mutagenesis and tested purified wild-type and mutant proteins for binding to an algD DNA fragment containing an AmrZ-binding site (Fig. 4B to E).

As the concentration of wild-type six-His AmrZ increases (Fig. (Fig.4B),4B), the AmrZ-algD complexes were observed and eventually shifted away 100% of the free DNA (Fig. (Fig.4B,4B, lanes 2 to 10). Distinct complex formation was observed at higher concentrations of six-His AmrZ only (Fig. (Fig.4B,4B, compare lanes 5 to 7 with lanes 8 to 10). Similar to wild-type AmrZ, AmrZ V20A bound to algD DNA (Fig. (Fig.4D),4D), and this mutant protein was capable of shifting 100% of the free DNA at high protein concentrations (Fig. (Fig.4D,4D, lanes 7 to 10). The migration patterns of the complexes formed by AmrZ V20A differ from wild-type AmrZ in that the most distinct complex appears to migrate much higher in the gel than that observed for the wild type (compare Fig. 4B and D, lanes 2 to 7). In contrast to wild-type AmrZ, AmrZ K18A and AmrZ R22A demonstrated a complete loss of DNA-binding activity (Fig. 4C and E, respectively). This suggests that residues K18 and R22 are absolutely required for AmrZ-mediated DNA-binding activity at algD.

To test the effect of these mutations in vivo, we utilized gene replacement strategies to construct isogenic strains expressing these AmrZ mutant proteins in place of wild-type AmrZ (see Material and Methods). The amrZ deletion WFPA205 shows no TM (Fig. (Fig.5).5). However, complementation of the amrZ deletion with wild-type amrZ (WFPA510) restored the TM+ phenotype (note that strain WFPA510 demonstrates a twitching zone identical to that of PAO1 [Fig. [Fig.5]).5]). The strains with mutations in residues required for AmrZ DNA binding and/or activation at algD are shown at the bottom of the plate (Fig. (Fig.5).5). In each situation, there is no detectable TM, demonstrating that these amino acids are required for TM. Since AmrZ V20A is able to bind the algD DNA in a manner similar to that of the wild-type AmrZ protein, this may indicate either a function for this residue other than DNA binding or that AmrZ V20A is defective in steps after DNA binding. Transmission electron microscopy was used to analyze the surface of the strains. The complemented strain (Fig. (Fig.6A)6A) demonstrates wild-type TFP (compare with Fig. Fig.2A).2A). In contrast, bacteria harboring AmrZ K18A, AmrZ V20A, or AmrZ R22A do not express detectable surface TFP (Fig. 6B to D). This demonstrates that a mutation of any of these residues results in the apiliate appearance of an amrZ null strain and suggests that the DNA-binding activity of AmrZ is essential for TM. Unfortunately, the amount of AmrZ produced by wild-type PAO1 and PAO1-derived strains with the above AmrZ variants are below the level of detection by Western blotting. However, when these constructs were placed in a mucoid strain background, AmrZ was readily detectable (P. J. Baynham and D. J. Wozniak, unpublished data).

FIG. 5.
TM analysis of amrZ alleles with a mutation in the DNA-binding domain. Strains analyzed were PAO1 (wild type), WFPA510 (amrZ deletion complemented with WT amrZ), WFPA511 (amrZ K18A), WFPA512 (amrZ V20A), WFPA513 (amrZ R22A), and WFPA205 (amrZ deletion). ...
FIG. 6.
TEM analysis of P. aeruginosa strains containing DNA-binding-domain mutations. Bacteria were harvested from plates cultured overnight, negatively stained using 2% uracyl acetate, and visualized using a Philips TEM 400. Strains analyzed were all PAO1 derivatives: ...


Previously, we identified AmrZ as a proposed RHH DNA-binding protein absolutely required for algD transcription in mucoid P. aeruginosa strain FRD1 (1). Since these strains are mucoid due to mutations that lead to alginate overproduction, we wanted to examine if amrZ had any role in nonmucoid strains of P. aeruginosa. In these studies, we constructed an amrZ deletion in nonmucoid PAO1 that resulted in a TM phenotype. Since an algD deletion remains TM+, this provides strong evidence that AmrZ enhances TM through some mechanism other than algD activation. Furthermore, mutagenesis of three amino acids crucial for AmrZ DNA binding reveals that the DNA-binding activity is required for its function in promoting TM. We also examined whether amrZ is involved in pilA expression or PilA maturation. To address this, we performed TEM and Western blot analysis of surface and whole-cell preparations. A deletion in amrZ resulted in no detectable pili on the surface of the cells via TEM. The Western blot analysis showed that PilA present in the whole-cell preparation of the deletion strains was of the same size and amount as that present in the wild type. However, there were only trace amounts of surface-localized PilA in the amrZ mutants. This reveals a defect in TFP surface localization in the amrZ deletion strain. The involvement of amrZ in TM is confirmed by previous studies in which an elaborate transposon library was constructed and then screened for mutations that result in a loss of TM. Although these studies were not pursued, Jacobs et al. also discovered that a mutation in amrZ (PA3385) exhibited a TM phenotype (20).

It is not unusual for regulators of algD to have roles in the regulation of other genes. Since alginate may afford protection from environmental stresses encountered during infection (12, 36, 47), having regulators coordinately controlling other genes necessary for successful infection would be an advantage. Integration host factor is required for full algD activation and also functions in the regulation of enzymes involved in heme biosynthesis, which occurs largely under anaerobic conditions (23, 48). In addition to alginate production, AlgR has been shown to regulate TM and cyanide production (7, 43). AmrZ also regulates multiple genes, functioning as an activator of algD and a repressor of its own synthesis (1, 2, 31), and data from this study demonstrate an additional role for AmrZ in TM.

Both AmrZ and AlgR bind the algD promoter and are required for algD activation (1, 11), although the exact mechanism of activation is not known. It is not clear whether a precise three-dimensional structure is required for RNA polymerase binding or if there may be specific protein-protein interactions in which one or both of these regulators participate. Since AlgR and AmrZ both participate in algD activation and regulate TM (43), it is interesting to speculate that they may both be required for expression of the gene(s) involved in TFP assembly and localization. Consistent with this hypothesis is the finding that both amrZ and algR mutants exhibit similar TM phenotypes (45). Recently, it has been found that the TM genes under AlgR control are in the fimTU-pilVWXY1Y2E operon (26). A DNA-binding consensus for AmrZ has recently been proposed: 5′-gGCCAttACCagcc-3 (31). Upon examination of the fimTU-pilVWXY1Y2E operon, there does not appear to be any obvious AmrZ DNA-binding site (P. J. Baynham, unpublished data). AlgR binding to this promoter has not been demonstrated, and so both AmrZ and AlgR may regulate this promoter indirectly. An attempt to complement the amrZ deletion with a plasmid (pVDtacPIL, a gift of M. J. Schurr) containing the fimTU-pilVWXY1Y2E operon was unsuccessful, while an algR deletion strain was complemented in tandem, supporting the hypothesis that AmrZ regulates TM in some other manner (data not shown). Since AmrZ has both activator and repressor functions (1, 31), it is unclear how AmrZ may control TM in P. aeruginosa. Genomics experiments in progress should elucidate the AmrZ-dependent genes involved in TM and TFP biogenesis.

P. aeruginosa has a number of virulence factors, which include an array of extracellular proteases, toxins, the ability to form biofilms, and type III secretion. Additionally, there are a number of regulators that control more than one P. aeruginosa virulence factor. For example, vfr is necessary for exotoxin A and protease production (41). The quorum sensing systems control a plethora of virulence traits, including elastases, alkaline protease, exotoxin A, and pyocyanin (5, 25, 32, 34). Likewise, a three-component regulatory network controls both biofilm development and the type III secretion system (24).

As our knowledge of bacterial gene regulation advances, the coordinate regulation of virulence factors is elucidated (7, 24, 43, 44). An understanding of how this regulation occurs is central to determining how to counter these traits. The targeting of important regulators may be an effective strategy after the determination of how they function. The examination of the role of AmrZ in TM is a crucial step in this process.


This work was supported by RUI grant 0113459 (0443186) from the National Science Foundation (P.J.B.). D.J.W. was supported by Public Health Service grants AI-35177 and HL-58334. D.M.R. was supported by American Heart Association predoctoral fellowship 0215191U.

We thank Randall Irvin for generously providing the antipilin antibodies. We also appreciate the generosity of Michael Schurr in providing the pVDtacPIL plasmid. Appreciation is expressed to Samuel Woolwine for assistance with his plasmid constructs. We also thank Haiping Lu for technical support.


1. Baynham, P. J., A. L. Brown, L. L. Hall, and D. J. Wozniak. 1999. Pseudomonas aeruginosa AlgZ, a ribbon-helix-helix DNA-binding protein, is essential for alginate synthesis and algD transcriptional activation. Mol. Microbiol. 33:1069-1080. [PubMed]
2. Baynham, P. J., and D. J. Wozniak. 1996. Identification and characterization of AlgZ, an AlgT-dependent DNA-binding protein required for Pseudomonas aeruginosa algD transcription. Mol. Microbiol. 22:97-108. [PubMed]
3. Boucher, J. C., J. Martinez-Salazar, M. J. Schurr, M. H. Mudd, H. Yu, and V. Deretic. 1996. Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA. J. Bacteriol. 178:511-523. [PMC free article] [PubMed]
4. Bradley, D. E. 1980. A function of Pseudomonas aeruginosa PAO polar pili: twitching motility. Can. J. Microbiol. 26:146-154. [PubMed]
5. Brint, J. M., and D. E. Ohman. 1995. Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. J. Bacteriol. 177:7155-7163. [PMC free article] [PubMed]
6. Burgering, M. J., R. Boelens, D. E. Gilbert, J. N. Breg, K. L. Knight, R. T. Sauer, and R. Kaptein. 1994. Solution structure of dimeric Mnt repressor (1-76). Biochemistry 33:15036-15045. [PubMed]
7. Carterson, A. J., L. A. Morici, D. W. Jackson, A. Frisk, S. E. Lizewski, R. Jupiter, K. Simpson, D. A. Kunz, S. H. Davis, J. R. Schurr, D. J. Hassett, and M. J. Schurr. 2004. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. J. Bacteriol. 186:6837-6844. [PMC free article] [PubMed]
8. Chivers, P. T., and R. T. Sauer. 2002. NikR repressor: high-affinity nickel binding to the C-terminal domain regulates binding to operator DNA. Chem. Biol. 9:1141-1148. [PubMed]
9. Comolli, J. C., A. R. Hauser, L. Waite, C. B. Whitchurch, J. S. Mattick, and J. N. Engel. 1999. Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia. Infect. Immun. 67:3625-3630. [PMC free article] [PubMed]
10. Deretic, V., J. F. Gill, and A. M. Chakrabarty. 1987. Gene algD coding for GDPmannose dehydrogenase is transcriptionally activated in mucoid Pseudomonas aeruginosa. J. Bacteriol. 169:351-358. [PMC free article] [PubMed]
11. Deretic, V., J. F. Gill, and A. M. Chakrabarty. 1987. Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD gene. Nucleic Acids Res. 15:4567-4581. [PMC free article] [PubMed]
12. Deretic, V., M. J. Schurr, and H. Yu. 1995. Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis. Trends Microbiol. 3:351-356. [PubMed]
13. DeVries, C. A., and D. E. Ohman. 1994. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation. J. Bacteriol. 176:6677-6687. [PMC free article] [PubMed]
14. Evans, L. R., and A. Linker. 1973. Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa. J. Bacteriol. 116:915-924. [PMC free article] [PubMed]
15. Goldberg, J. B., W. L. Gorman, J. L. Flynn, and D. E. Ohman. 1993. A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J. Bacteriol. 175:1303-1308. [PMC free article] [PubMed]
16. Govan, J. R., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574. [PMC free article] [PubMed]
17. Govan, J. R., and G. S. Harris. 1986. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol. Sci. 3:302-308. [PubMed]
18. Guzman, L. M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose pBAD promoter. J. Bacteriol. 177:4121-4130. [PMC free article] [PubMed]
19. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86. [PubMed]
20. Jacobs, M. A., A. Alwood, I. Thaipisuttikul, D. Spencer, E. Haugen, S. Ernst, O. Will, R. Kaul, C. Raymond, R. Levy, L. Chun-Rong, D. Guenthner, D. Bovee, M. V. Olson, and C. Manoil. 2003. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 100:14339-14344. [PMC free article] [PubMed]
21. Knight, K. L., and R. T. Sauer. 1992. Biochemical and genetic analysis of operator contacts made by residues within the beta-sheet DNA binding motif of Mnt repressor. EMBO J. 11:215-223. [PMC free article] [PubMed]
22. Knight, K. L., and R. T. Sauer. 1989. DNA binding specificity of the Arc and Mnt repressors is determined by a short region of N-terminal residues. Proc. Natl. Acad. Sci. USA 86:797-801. [PMC free article] [PubMed]
23. Krieger, R., A. Rompf, M. Schobert, and D. Jahn. 2002. The Pseudomonas aeruginosa hemA promoter is regulated by Anr, Dnr, NarL and integration host factor. Mol. Genet. Genomics 267:409-417. [PubMed]
24. Kuchma, S. L., J. P. Connolly, and G. A. O'Toole. 2005. A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa. J. Bacteriol. 187:1441-1454. [PMC free article] [PubMed]
25. Latifi, A., M. K. Winson, M. Foglino, B. W. Bycroft, G. S. Stewart, A. Lazdunski, and P. Williams. 1995. Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol. Microbiol. 17:333-343. [PubMed]
26. Lizewski, S. E., J. R. Schurr, D. W. Jackson, A. Frisk, A. J. Carterson, and M. J. Schurr. 2004. Identification of AlgR-regulated genes in Pseudomonas aeruginosa by use of microarray analysis. J. Bacteriol. 186:5672-5684. [PMC free article] [PubMed]
27. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2:1051-1060. [PubMed]
28. Martin, D. W., B. W. Holloway, and V. Deretic. 1993. Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor. J. Bacteriol. 175:1153-1164. [PMC free article] [PubMed]
29. Martin, D. W., M. J. Schurr, M. H. Mudd, J. R. Govan, B. W. Holloway, and V. Deretic. 1993. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 90:8377-8381. [PMC free article] [PubMed]
30. Mattick, J. S. 2002. Type IV pili and twitching motility. Annu. Rev. Microbiol. 56:289-314. [PubMed]
31. Ramsey, D. M., P. J. Baynham, and D. J. Wozniak. 2005. Binding of Pseudomonas aeruginosa AlgZ to sites upstream of the algZ promoter leads to repression of transcription. J. Bacteriol. 187:4430-4443. [PMC free article] [PubMed]
32. Rumbaugh, K. P., J. A. Griswold, and A. N. Hamood. 1999. Contribution of the regulatory gene lasR to the pathogenesis of Pseudomonas aeruginosa infection of burned mice. J. Burn Care Rehabil. 20:42-49. [PubMed]
33. Schweizer, H. P. 1992. Allelic exchange in Pseudomonas aeruginosa using novel ColE1-type vectors and a family of cassettes containing a portable oriT and the counter-selectable Bacillus subtilis sacB marker. Mol. Microbiol. 6:1195-1204. [PubMed]
34. Seed, P. C., L. Passador, and B. H. Iglewski. 1995. Activation of the Pseudomonas aeruginosa lasI gene by LasR and the Pseudomonas autoinducer PAI: an autoinduction regulatory hierarchy. J. Bacteriol. 177:654-659. [PMC free article] [PubMed]
35. Semmler, A. B., C. B. Whitchurch, and J. S. Mattick. 1999. A re-examination of twitching motility in Pseudomonas aeruginosa. Microbiology 145:2863-2873. [PubMed]
36. Simpson, J. A., S. E. Smith, and R. T. Dean. 1988. Alginate inhibition of the uptake of Pseudomonas aeruginosa by macrophages. J. Gen. Microbiol. 134:29-36. [PubMed]
37. Tateno, M., K. Yamasaki, N. Amano, J. Kakinuma, H. Koike, M. D. Allen, and M. Suzuki. 1997. DNA recognition by β-sheets. Biopolymers 44:335-359. [PubMed]
38. van Schaik, E. J., C. L. Giltner, G. F. Audette, D. W. Keizer, D. L. Bautista, C. M. Slupsky, B. D. Sykes, and R. T. Irvin. 2005. DNA binding: a novel function of Pseudomonas aeruginosa type IV pili. J. Bacteriol. 187:1455-1464. [PMC free article] [PubMed]
39. Vershon, A. K., S. M. Liao, W. R. McClure, and R. T. Sauer. 1987. Bacteriophage P22 Mnt repressor. DNA binding and effects on transcription in vitro. J. Mol. Biol. 195:311-322. [PubMed]
40. Waldburger, C. D., and R. T. Sauer. 1995. Domains of Mnt repressor: roles in tetramer formation, protein stability, and operator DNA binding. Biochemistry 34:13109-13116. [PubMed]
41. West, S. E. H., A. K. Sample, and L. J. Runyen-Janecky. 1994. The vfr gene product, required for Pseudomonas aeruginosa exotoxin A and protease production, belongs to the cyclic AMP receptor protein family. J. Bacteriol. 176:7532-7542. [PMC free article] [PubMed]
42. West, S. E., H. P. Schweizer, C. Dall, A. K. Sample, and L. J. Runyen-Janecky. 1994. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 148:81-86. [PubMed]
43. Whitchurch, C. B., R. A. Alm, and J. S. Mattick. 1996. The alginate regulator AlgR and an associated sensor FimS are required for twitching motility in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 93:9839-9843. [PMC free article] [PubMed]
44. Whitchurch, C. B., S. A. Beatson, J. C. Comolli, T. Jakobsen, J. L. Sargent, J. J. Bertrand, J. West, M. Klausen, L. L. Waite, P. J. Kang, T. Tolker-Nielsen, J. S. Mattick, and J. N. Engel. 2005. Pseudomonas aeruginosa fimL regulates multiple virulence functions by intersecting with Vfr-modulated pathways. Mol. Microbiol. 55:1357-1378. [PMC free article] [PubMed]
45. Whitchurch, C. B., T. E. Erova, J. A. Emery, J. L. Sargent, J. M. Harris, A. B. T. Semmler, M. D. Young, J. S. Mattick, and D. J. Wozniak. 2002. Phosphorylation of the Pseudomonas aeruginosa response regulator AlgR is essential for type IV fimbria-mediated twitching motility. J. Bacteriol. 184:4544-4554. [PMC free article] [PubMed]
46. Woolwine, S. C., A. B. Sprinkle, and D. J. Wozniak. 2001. Loss of Pseudomonas aeruginosa PhpA aminopeptidase activity results in increased algD transcription. J. Bacteriol. 183:4674-4679. [PMC free article] [PubMed]
47. Worlitzsch, D., R. Tarran, M. Ulrich, U. Schwab, A. Cekici, K. C. Meyer, P. Birrer, G. Bellon, J. Berger, T. Weiss, K. Botzenhart, J. R. Yankaskas, S. Randell, R. C. Boucher, and G. Doring. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Investig. 109:317-325. [PMC free article] [PubMed]
48. Wozniak, D. J. 1994. Integration host factor and sequences downstream of the Pseudomonas aeruginosa algD transcription start site are required for expression. J. Bacteriol. 176:5068-5076. [PMC free article] [PubMed]
49. Wozniak, D. J., and D. E. Ohman. 1994. Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT. J. Bacteriol. 176:6007-6014. [PMC free article] [PubMed]
50. Wozniak, D. J., A. B. Sprinkle, and P. J. Baynham. 2003. Control of Pseudomonas aeruginosa algZ expression by the alternative sigma factor AlgT. J. Bacteriol. 185:7297-7300. [PMC free article] [PubMed]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)
PubReader format: click here to try


Save items

Related citations in PubMed

Cited by other articles in PMC

See all...


  • Compound
    PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
  • MedGen
    Related information in MedGen
  • Nucleotide
    Primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
  • Pathways + GO
    Pathways + GO
    Pathways and biological systems (BioSystems) that cite the current articles. Citations are from the BioSystems source databases (KEGG and BioCyc).
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...